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Heparin, an anionic polysaccharide, inhibited the ferredoxin-catalyzed reduction of 
NADP in spinach chloroplast thylakoid membranes. Under the same conditions of 
assay, heparin did not interfere markedly with photoreduction of methyl viologen, 
anthraquinone sulfonate, or ferredoxin. A kinetic analysis of the heparin-induced 
interference with NADP photoreduction showed partial competitive inhibition. Heparin 
also interfered with NADPH oxidation by membrane-bound ferredoxin-NADP reduc- 
tase (with dichlorophenol-indophenol as the acceptor) by a mechanism that involves 
partial competitive inhibition. This reaction was sensitive to the presence of salts; 
increasing ionic strength increases the heparin Ki for inhibition of NADPH oxidation. 
These results show that heparin binds to ferredoxin-NADP reductase, and in doing 
so interferes with binding to the reductase by both ferredoxin and NADP(H). Since 
heparin is redox inactive and does not interfere with the photophosphorylation 
reaction, it is a useful inhibitor of thylakoid membrane reactions which require the 
catalytic activity of ferredoxin-NADP reductase. (0 1985 Academic Press, Inc. 
Spinach ferredoxin-NADP reductase 
(FNR)3 is a membrane-bound flavopro- 
tein which catalyzes several two-electron 
transfer reactions, including ferredoxin- 
mediated NADP reduction (l-3) and the 
reduction of various dyes by NADPH 
(diaphorase reaction) (4, 5). The flavopro- 
tein contains separate binding sites for 
ferredoxin and NADP(H) (6); binary com- 
plexes of ferredoxin and FNR and of 
NADP and FNR have been shown to occur 
(7-9). Both of these complexes dissociate 
as the ionic strength of the medium is 
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3 Abbreviations used: FNR, ferredoxin-NADP re- 
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tosystem; AQS, anthraquinone-2-sulfonate; Tricine, 
N-[2-hydroxy-l,l- bis(hydroxymethyl)ethyllglycine; 
Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid; DCPIP, dichlorophenolindophenol; MeV, methyl 
viologen. 
increased (9), suggesting that ferredoxin 
and NADP(H) binding to FNR depends 
primarily upon ionic interactions. 
Reversible inhibition has been demon- 
strated at both the ferredoxin and pyri- 
dine nucleotide binding sites of FNR. 
Competitive inhibition of NADP binding 
by 2’-AMP during a transhydrogenase re- 
action was demonstrated by Keister et al. 
(l), while inorganic pyrophosphate com- 
petitively inhibits ferredoxin binding dur- 
ing NADP photoreduction in isolated thy- 
lakoids, and inhibits the formation of the 
ferredoxin:FNR complex (10). Whole-chain 
electron transport from Ha0 to methyl 
viologen is unaffected by pyrophosphate, 
but the high concentration of pyrophos- 
phate required to inhibit NADP reduction 
(K? = 9.7 mM) may be undesirable during 
assays of photosynthetic phosphorylation. 
We therefore sought an alternate inhibitor 
which would reversibly prevent ferredoxin 
binding to FNR. The use of a non-redox- 
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active molecule is desirable in order to 
eliminate any competing electron transfer 
activity. One possibility would be the use 
of apoferredoxin, prepared by removing 
the Fe/S center from the protein. This, 
however, is a costly procedure in terms of 
the amounts of native protein needed to 
prepare sufficient apoferredoxin for many 
experiments. Another approach would be 
to use a readily available, non-redox-active 
molecule with a molecular weight and 
ionic composition similar to ferredoxin. 
The polysaccharide heparin meets these 
qualifications. 
Since heparin is composed of repeating 
dimers of glucosamine and glucuronic acid, 
and each dimer contains one carboxyl and 
two sulfate groups (ll), the molecule is 
polyanionic at physiological pH. Measure- 
ments of heparin molecular weights range 
from 6000 to 18,000; however, the value of 
17,000 kDa was chosen for concentration 
calculations in the experiments reported 
here based on the conclusions of Sumyk 
and Yocum (12). Heparin will not catalyze 
electron transfer; therefore, with some 
obvious limitations, heparin can be con- 
sidered a non-redox-active ionic analog of 
ferredoxin. Our results show that heparin 
inhibits both ferredoxin and NADPH 
binding to membrane-bound FNR. The 
inhibitory heparin:FNR complex shares a 
number of properties with the ferre- 
doxin:FNR complex. 
MATERIALS AND METHODS 
Spinach thylakoid membranes were prepared by 
the method of Robinson and Yocum (13). Ferredoxin 
was purified from spinach as described by Petering 
and Palmer (14), with the modifications of Yocum (15). 
Assays of NADP photoreduction were performed 
in a reaction mixture containing 50 mM Tricine (pH 
8.0), 50 mM NaCI, 3 mM MgClz, 5 mM NaHzPO,, 1 
mM ADP, 10 KM ferredoxin (unless otherwise speci- 
fied), 1 mM NADP, and 30/40 pg Chl in a total 
volume of 1.5 ml. The rate of NADP reduction was 
measured by oxygen evolution in the presence of 840 
units of catalase. This method was carefully cali- 
brated to actual NADPH formation by measuring 
the concentration of photoreduced NADPH by oxi- 
dation with phenazine methosulfate. Two mole 
equivalents of NADP were reduced for every mole 
equivalent of oxygen evolved. Electron transport 
to other PSI acceptors (ferredoxin/oxygen, AQS, 
Fe(CN)g-, MeV) was assayed in the reaction mixture 
described for NADP reduction, but without the 
addition of ferredoxin/NADP and catalase. Rates of 
oxygen evolution and uptake associated with the 
various electron transport reactions were measured 
with a Clark-type electrode fitted to a thermostatted 
(25°C) cuvette. Saturating light (lo6 ergs cm-* s-i) 
was provided by an Oriel Model 6235 light source 
filtered through 5 cm of an 0.2% solution of CuSO, 
and a red cut-on filter (>600 nm). 
The reduction of DCPIP by NADPH catalyzed by 
membrane-bound FNR was followed by the change 
in absorbance at 600 nm using an Aminco DW-2 
spectropbotometer in the split-beam mode. Identical 
stirred cuvettes containing 20 mM Hepes-NaOH (pH 
7.5), 66 pM DCPIP, and thylakoid membranes (13 fig 
Chl/ml) were prepared; the reaction was initiated 
by the injection of a small volume of NADPH into 
one of the cuvettes. The ionic strength of the medium 
was adjusted by dilution of the buffer, or by addition 
of NaCl. The slow rate of nonenzymatic reduction 
of DCPIP by NADPH was subtracted from all rates 
presented. 
Chlorophyll was determined by the method of 
Arnon (16). Heparin, NADP, NADPH, ADP, catalase, 
Tricine, Hepes, and DCPIP were obtained from 
Sigma. Anthraquinone sulfonate was obtained from 
Eastman Organics and recrystallized; methyl viologen 
was purchased from Aldrich. All other chemicals 
used were of the purest grades commercially avail- 
able. 
RESULTS 
Low concentrations of heparin effec- 
tively inhibit electron transport through 
FNR to NADP; NADP photoreduction, 
mediated by 10 PM ferredoxin, was 60% 
inhibited by 20 PM heparin (Fig. 1). Higher 
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FIG. 1. Inhibition of photosynthetic NADP reduc- 
tion by heparin. Assay conditions are described 
under Materials and Methods. 
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concentrations of heparin (100 PM) inhib- 
ited the rate of NADP reduction by 66%, 
while ferredoxin-mediated oxygen reduc- 
tion, catalyzed by 21 PM ferredoxin in the 
absence of NADP, was only 9% inhibited 
by 10 PM heparin, and 19% by 100 PM 
heparin (Table I). This latter reaction 
presumably does not require FNR. Elec- 
tron transport to other negatively charged 
PSI acceptors was only minimally affected 
by heparin; Table I shows that the rate 
of electron flow to AQS and Fe(CN)g- is 
inhibited 9% by 10 PM heparin. This slight 
inhibition may be due to ionic competition 
between negatively charged species (hep- 
arin and the acceptor) for the site of 
reduction at PSI. The addition of 100 PM 
heparin had a greater effect on electron 
Ilow to ferredoxin/oxygen than it did when 
AQS or Fe(CN)i- were used as acceptors 
(Table I). The higher molecular weight of 
ferredoxin may account for this greater 
sensitivity. Electron transport to the cat- 
ionic acceptor MeV was unaffected by 10 
PM heparin, and was inhibited less than 
5% by 100 PM heparin (Table I). This 
observation supports the hypothesis of a 
weak ionic competition between heparin 
and negatively charged electron acceptors, 
and also provides strong evidence that 
the membrane-bound components of the 
electron transport chain prior to FNR are 
insensitive to inhibition by heparin. 
Double-reciprocal plots were used to 
analyze the inhibition exerted by heparin 
on NADP reduction. A plot of l/[ferre- 
doxin] vs l/v in the absence and presence 
of varying concentrations of heparin pro- 
duced a family of lines which intersect on 
the l/v axis, suggesting a competitive 
interaction between ferredoxin and hep- 
arin (Fig. 2a). These results are best ex- 
plained by heparin inhibition of ferredoxin 
binding to FNR. Dixon plots of these data 
(l/v vs heparin concentration) were non- 
linear (Fig. 2b), indicating that heparin 
inhibition of ferredoxin binding to FNR 
was of a partial competitive nature (17). 
Thus, while heparin interferes with bind- 
ing of ferredoxin to FNR, both native and 
inhibited reductase are able to mediate 
electron flow from ferredoxin to NADP. 
The inhibited reductase, however, cata- 
lyzed the reaction at a slower rate. The 
Ki for the heparin:FNR interaction (de- 
termined following (18)) was 0.3 @M, while 
the Km for ferredoxin in this reaction was 
measured to be 4.0 PM. 
Doubling the NADP concentration to 2 
mM during ferredoxin-mediated NADP 
reduction was found to slightly relieve 
the inhibition by heparin at low heparin 
concentrations, while reducing the NADP 
concentration to 0.5 mM was without effect 
(data not shown). This result suggests 
that high concentrations of NADP produce 
a weak effect on the binding of heparin 
to FNR under the conditions used to assay 
NADP reduction. The possible interaction 
of heparin with the pyridine nucleotide 
binding site on FNR can be elucidated in 
the absence of ferredoxin by examining 
TABLE I 
EFFECTOFHEPARINONELECTRON TRANSPORTTO ANIONICANDCATIONIC PSI ACCEPTORS 
Heparin 
(FM) FD/NADP FD 
Electron Transport 
FE(CN)63- AQS MeV 
0 150 96 146 230 223 
10 77 90 136 212 222 
100 51 78 132 207 211 
Note. Assay conditions are described under Materials and Methods. The concentrations of PSI acceptors 
were 10 pM ferredoxin/l mM NADP (plus 840 units of catalase) for NADP reduction, 21 PM ferredoxin when 
used alone for ferredoxin-mediated oxygen reduction, 2.5 mM Fe(CN)6 a- 10 pM AQS, and 6’7 pM MeV. Electron , 
transport rates are expressed as pmol O2 h-’ mg Chl-‘. 
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FIG. 2. Partial competitive kinetics of heparin 
inhibition of NADP reduction. (a) Double-reciprocal 
plots with ferredoxin as the varying substrate. Assay 
conditions are described under Materials and Meth- 
ods. Values in parentheses represent the concentra- 
tion (PM) of heparin added to the reaction. (b) Dixon 
plots at various ferredoxin concentrations. Ferredoxin 
concentrations (PM) are given in parentheses. 
the effect of heparin on the diaphorase 
reaction (NADPH - FNR - DCPIP) un- 
der a variety of conditions. 
The FNR-catalyzed reduction of DCPIP 
by NADPH at low ionic strength was 
inhibited by concentrations of heparin 
lOO-fold less than those required to in- 
hibit ferrecloxin-mediated NADP recluc- 
tion (Fig. 3). As Fig. 3 also shows, increas- 
ing the NADPH concentration in the assay 
to 1 mM decreased the extent of heparin 
inhibition of the diaphorase reaction; at 
this NADPH concentration, a maximal 
inhibition of 23% was observed, in contrast 
“20_. 
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FIG. 3. Inhibition of the diaphorase reaction by 
heparin. Assays of DCPIP reduction catalyzed by 
membrane-bound FNR were performed as described 
under Materials and Methods. The reactions were 
initiated by the addition of NADPH to a final 
concentration of 40 pM (M) or of I mM (0). 
to the 56% inhibition obtained with 40 PM 
NADPH as the substrate. Kinetic analysis 
of heparin inhibition of the diaphorase 
reaction showed a family of lines which 
converged on the l/v axis (Fig. 4). Dixon 
plots were not presented, but could be 
seen by inspection of Fig. 4 to have been 
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FIG. 4. Partial competitive kinetics of heparin 
inhibition of the diaphorase reaction. Double- recip- 
rocal plots with NADPH as the varying substrate 
are presented. Assay conditions are given under 
Materials and Methods. Values in parentheses rep- 
resent the concentration (nM) of heparin added to 
the reaction. 
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nonlinear. Therefore, heparin was par- 
tially competitive with respect to NADPH 
in the diaphorase reaction, and partially 
competitive with respect to ferredoxin 
during NADP reduction. The K, for 
NADPH in the diaphorase reaction was 
measured to be 6.3 pM, while the Ki of 
the heparin:FNR association (determined 
as above) was 5 nM. 
Ferredoxin by itself is partially com- 
petitive with respect to NADPH during 
assays of DCPIP reduction at low ionic 
strength (19); the inhibition is reversed 
by the addition of NaCl. Similarly, heparin 
inhibition of the diaphorase reaction can 
be largely relieved by an increase in the 
ionic strength of the medium. In the pres- 
ence of 80 ITIM NaCl or greater, the rate 
of DCPIP reduction was approximately 
75% that of uninhibited reaction, and the 
Ki of the heparin:FNR association in- 
creased with ionic strength from 5 nM at 
20 mM NaCl, to 1 PM at 150 mM NaCl (data 
not shown). This decrease in heparin in- 
hibition with increasing ionic strength is 
probably due to the dissociation of a hep- 
arin:FNR complex stabilized by ionic in- 
teractions. 
DISCUSSION 
Micromolar concentrations of heparin 
have little effect on the reduction of fer- 
redoxin by PSI, but effectively inhibit 
ferredoxin-mediated NADP reduction by 
inhibiting ferredoxin binding to FNR in 
a partially competitive manner. The FNR- 
catalyzed reduction of DCPIP by NADPH 
is inhibited by heparin in a similar man- 
ner. In the latter case the inhibition is 
largely, but not completely, relieved by 
increasing the ionic strength of the me- 
dium or by increasing the concentration 
of NADPH. While heparin inhibits the 
binding of both ferredoxin and pyridine 
nucleotides to FNR, under the conditions 
used to measure NADP reduction (an ionic 
strength of 120 mM and a pyridine nucleo- 
tide concentration of 1 mM), the major 
effect involves interference with ferre- 
doxin binding to FNR. Likewise, the ex- 
periments involving heparin inhibition of 
the diaphorase reaction reveal a number 
of similarities between the interaction of 
heparin and of ferredoxin with FNR. Like 
heparin, ferredoxin competes partially 
with NADPH for binding to FNR at low 
ionic strength (I= 10 mM) (19). Both fer- 
redoxin and heparin are more tightly 
bound to FNR under low salt conditions, 
as evidenced by their similar K, values, 
for inhibition of the diaphorase reaction 
[5 nM for heparin vs 1.9 nM for ferredoxin 
(19)]. At an intermediate ionic strength 
(I = 50-100 mM) ferredoxin stimulates the 
diaphorase reaction (19, 20), apparently 
by enhancing the association of DCPIP 
with FNR. The degree of stimulation 
declines with increasing ionic strength, 
reflecting both the dissociation of the fer- 
redoxin:FNR complex (20) and the inac- 
tivation of FNR by high salt concentra- 
tions (19). We have observed that the 
inhibitory heparin:FNR complex disso- 
ciates with increasing ionic strength (Ki 
increases from 5 nM to 1 j&M), indicating 
that this complex, like that of ferre- 
doxin:FNR, depends primarily upon ionic 
interactions. While both heparin and fer- 
redoxin form ionic complexes with FNR 
which inhibit the diaphorase reaction, 
heparin fails to stimulate the reaction at 
higher ionic strengths. 
The data obtained for the diaphorase 
reaction initiated by 1 mM NADPH (Fig. 
3) are consistent with an increased Ki for 
heparin in the presence of high concen- 
trations of pyridine nucleotide. This de- 
creased association of heparin with FNR 
can be compared to earlier kinetic studies 
which show that both NADPH and NADP 
inhibit ferredoxin binding to FNR (21). 
These results can also be compared to a 
recent report that 0.5 mM NADP increases 
the Kd of the ferredoxin:FNR complex at 
least 14-fold (22). 
The kinetic analyses presented in this 
paper indicate that heparin does not com- 
pletely prevent the binding of ferredoxin 
or NADPH to FNR, but rather increases 
the KS for both substrates. This type of 
behavior could arise from heparin binding 
at a site or sites which overlap the fer- 
redoxin and pyridine nucleotide binding 
sites on FNR, or from binding at a site 
which is distinct from these sites, but 
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from which heparin can affect ligand 
binding. While our data do not identify 
the site of heparin binding, an estimation 
of the number of heparin binding sites on 
FNR can be made from the data of Fig. 
3. Heparin is tightly bound to FNR at low 
ionic strength, and under these conditions 
the inhibition pattern is clearly biphasic 
with increasing heparin concentration. 
The intersection of tangents to the two 
slopes falls at 20 nM heparin. This concen- 
tration of the polysaccharide accounts for 
73% of the total inhibition seen using 500 
nM heparin. The concentration of FNR 
present in the experiment can be esti- 
mated on the basis of chlorophyll concen- 
tration using the results in (23). When 
this was done, the ratio of heparin to 
FNR at 20 nM heparin was found to be 
1:3.5. Heparin may be acting to aggregate 
membrane-bound FNR; in any event no 
more than one heparin binding site per 
FNR is indicated. 
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